T1	Participants 514 565	Twenty-six patients with relapsed Hodgkin's disease
T2	Participants 594 685	Their median age was 31 years (range, 22-59) and 14 patients were males and 12 were females
T3	Participants 687 827	Patients were pretreated with a median of eight cycles of cytotoxic chemotherapy, while 18 patients had undergone extended field irradiation
T4	Participants 2309 2343	in patients with Hodgkin's disease
